OPRX - OptimizeRx Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
23,798
21,206
12,127
7,751
7,221
Cost of Revenue
8,738
9,000
6,175
3,411
3,622
Gross Profit
15,060
12,207
5,953
4,340
3,598
Operating Expenses
Research Development
1,668
676
1,009
398
290
Selling General and Administrative
13,018
11,710
6,623
5,111
3,241
Total Operating Expenses
15,675
12,027
8,083
5,872
4,196
Operating Income or Loss
-615
180
-2,130
-1,532
-597
Interest Expense
-
-
0
0
0
Total Other Income/Expenses Net
-860
-608
-
-50
0
Income Before Tax
-1,268
226
-2,104
-1,539
-595
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
-1,268
226
-2,104
-1,539
-595
Net Income
-1,268
226
-2,104
-1,539
-595
Net Income available to common shareholders
-1,268
226
-2,104
-1,539
-595
Reported EPS
Basic
-
0.02
-0.21
-0.15
-0.06
Diluted
-
0.02
-0.21
-0.15
-0.06
Weighted average shares outstanding
Basic
-
10,832
9,820
9,903
8,187
Diluted
-
11,863
9,820
9,903
8,187
EBITDA
-
497
-1,779
-1,304
-261